Endocrine

Timing of GLP-1 receptor agonist treatment in pregnancy-related high blood pressure disorders

Updated

Abstract

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may improve metabolic health before conception.

  • The impact of GLP-1 RAs on hypertensive disorders of pregnancy (HDP) is not yet established.
  • There is a potential link between GLP-1 RAs and improved metabolic health in women planning for pregnancy.
  • Further research is needed to clarify the safety of GLP-1 RAs during early pregnancy.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

0 of 10
authors report competing interests
10 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free